Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statement

dc.contributor.authorOspina-serrano, Aylen Vanessa
dc.contributor.authorGonzález-larriba, Jose Luis
dc.contributor.authorNadal, Ernest
dc.contributor.authorHernando Trancho, Florentino
dc.contributor.authorBosch-barrera, Joaquim
dc.contributor.authorCalvo, Virginia
dc.contributor.authorBolufer-nadal, Sergio
dc.contributor.authorCampo-cañaveral De La Cruz, José Luis
dc.contributor.authorMacía-vidueira, Ivan
dc.contributor.authorÁlvarez-kindelán, Antonio
dc.contributor.authorDel Barco-morillo, Edel
dc.contributor.authorBernabé-caro, Reyes
dc.contributor.authorCasal-rubio, Joaquin
dc.contributor.authorCilleruelo-ramos, Ángel
dc.contributor.authorCobo-dols, Manuel
dc.contributor.authorDómine-gómez, Manuel
dc.contributor.authorFigueroa-almánzar, Santiago
dc.contributor.authorInsa-mollá, Amelia
dc.contributor.authorJarabo-sarceda, José Ramón
dc.contributor.authorJiménez-maestre, Unai
dc.contributor.authorLópez-castro, Rafael
dc.contributor.authorMajem, Margarita
dc.contributor.authorMartinez-marti, Alex
dc.contributor.authorMartínez Téllez, Elisabeth
dc.contributor.authorSánchez-lorente, David
dc.contributor.authorLópez-valcárcel, Marta
dc.contributor.authorCouñago, Felipe
dc.contributor.authorGarcia-campelo, Rosario
dc.contributor.authorDe Castro, Javier
dc.contributor.authorMassutí-sureda, Bartomeu
dc.contributor.authorProvencio, Mariano
dc.date.accessioned2025-11-13T10:34:01Z
dc.date.available2025-11-13T10:34:01Z
dc.date.issued2025-09-01
dc.date.updated2025-11-12T10:04:58Z
dc.description.abstractBackground: In light of the ongoing advancements in the treatment of patients with early- and locally advanced-stage non-small cell lung cancer (NSCLC), the members of the Spanish Lung Cancer Group (GECP) deemed it necessary to update its 2023 consensus suggestions for the management of these patients. Methods: From July to November 2024, a panel of experts, including thoracic surgeons, radiation oncologists, and medical oncologists, was convened. The consensus process was developed using a mixed approach that incorporated Delphi and nominal group techniques. The consensus coordination group reviewed the relevant scientific literature for the update and developed a questionnaire for the panel of experts to vote on. Two rounds of voting were conducted, followed by a final nominal group meeting to discuss clinical situations where consensus had not been reached and draw final conclusions. In instances where high-quality scientific data were not available or were the subject of controversy, final suggestions were based on the expertise of the participants. Results: Thirty experts from the multidisciplinary team participated in the voting and discussions. The document was updated to incorporate recent advancements in molecular diagnosis and biomarkers, the role of the multidisciplinary thoracic committee, criteria for neoadjuvant/perioperative treatment, approaches to inoperable/unresectable disease, and adjuvant treatment. Proposals that did not require updating were not voted on again and remain part of the document, maintaining their first version. Conclusions: Updated suggestions were developed for the most relevant situations in the treatment of patients with early-stage and locally advanced NSCLC. These suggestions will support clinical decisionmaking in daily practice. This paper presents the statements developed by the expert panel and summarizes the scientific evidence supporting them.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/2445/224340
dc.language.isoeng
dc.publisherAME Publishing Company
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.21037/tlcr-2025-619
dc.relation.ispartofTranslational Lung Cancer Research, 2025, vol. 14, issue. 9, p. 3299-3322
dc.relation.urihttps://doi.org/10.21037/tlcr-2025-619
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccess
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.titleMultidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statement
dc.typeinfo:eu-repo/semantics/article

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
tlcr-14-09-3299.pdf
Mida:
609.52 KB
Format:
Adobe Portable Document Format

Paquet de llicències

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
license.txt
Mida:
1.71 KB
Format:
Item-specific license agreed upon to submission
Descripció: